Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
(NASDAQ: FULC) Delayed: 3.79 +0.01 (0.26%)
Previous Close $3.78    52 Week High
Open $3.80    52 Week Low
Day High $3.81    P/E N/A 
Day Low $3.77    EPS
Volume 145,956